Hemophilia A

"Hemophilia A" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage.

Descriptor ID	D006467
MeSH Number(s)	C15.378.100.100.500 C15.378.100.141.500 C15.378.463.500 C16.320.099.500
Concept/Terms	Hemophilia A Hemophilia A Hemophilia As Hemophilia, Classic Hemophilia Hemophilia A, Congenital Congenital Hemophilia A Congenital Hemophilia As Hemophilia As, Congenital Classic Hemophilia Classic Hemophilias Hemophilias, Classic Haemophilia Autosomal Hemophilia A Autosomal Hemophilia A As, Autosomal Hemophilia Autosomal Hemophilia As Hemophilia A, Autosomal Hemophilia As, Autosomal Factor VIII Deficiency Factor VIII Deficiency Factor 8 Deficiency, Congenital Factor VIII Deficiency, Congenital Deficiency, Factor VIII

Below are MeSH descriptors whose meaning is more general than "Hemophilia A".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Hematologic Diseases [C15.378]
Blood Coagulation Disorders [C15.378.100]
Blood Coagulation Disorders, Inherited [C15.378.100.100]
Hemophilia A [C15.378.100.100.500]
Coagulation Protein Disorders [C15.378.100.141]
Hemophilia A [C15.378.100.141.500]
Hemorrhagic Disorders [C15.378.463]
Hemophilia A [C15.378.463.500]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Blood Coagulation Disorders, Inherited [C16.320.099]
Hemophilia A [C16.320.099.500]

Below are MeSH descriptors whose meaning is related to "Hemophilia A".

Below are MeSH descriptors whose meaning is more specific than "Hemophilia A".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hemophilia A" by people in this website by year, and whether "Hemophilia A" was a major or minor topic of these publications.

Bar chart showing 18 publications over 12 distinct years, with a maximum of 4 publications in 1996

To see the data from this visualization as text, click here.

Year	Major Topic	Total
1996	4	4
1999	1	1
2000	1	1
2001	2	2
2005	1	1
2011	1	1
2014	1	1
2016	1	1
2019	2	2
2021	1	1
2022	2	2
2023	1	1

Below are the most recent publications written about "Hemophilia A" by people in Profiles.

Bertolini TB, Herzog RW, Kumar SRP, Sherman A, Rana J, Kaczmarek R, Yamada K, Arisa S, Lillicrap D, Terhorst C, Daniell H, Biswas M. Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice. Cell Immunol. 2023 03; 385:104675.

View in: PubMed
Joo JH, Wang X, Singh S, Chen CY, Li C, Adair JE, Kiem HP, Rawlings DJ, Miao CH. Intraosseous delivery of platelet-targeted factor VIII lentiviral vector in humanized NBSGW mice. Blood Adv. 2022 10 11; 6(19):5556-5569.

View in: PubMed
Latef TJ, Bhardwaj P, Bilal M. Refractory acquired haemophilia A in a patient with HIV treated with Emicizumab. Blood Coagul Fibrinolysis. 2022 Mar 01; 33(2):138-140.

View in: PubMed
Barish J, Hajdenberg J. Severe bleeding after haemorrhoidal banding in a haemophilia patient treated with emicizumab. Haemophilia. 2021 Jul; 27(4):e589-e590.

View in: PubMed
Croteau SE, Frelinger AL, Gerrits AJ, Michelson AD. Decreased platelet surface phosphatidylserine predicts increased bleeding in patients with severe factor VIII deficiency. J Thromb Haemost. 2021 04; 19(4):976-982.

View in: PubMed
Gundabolu K, Goldsweig A, Bhatt VR, Koepsell SA, Harper JL. ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII. Haemophilia. 2020 Jan; 26(1):e5-e8.

View in: PubMed
Chang IJ, Byers HM, Ng BG, Merritt JL, Gilmore R, Shrimal S, Wei W, Zhang Y, Blair AB, Freeze HH, Zhang B, Lam C. Factor VIII and vWF deficiency in STT3A-CDG. J Inherit Metab Dis. 2019 03; 42(2):325-332.

View in: PubMed
Patel MD, Hajdenberg J. Successful treatment of chronic recurrent life-threatening bleeding due to an acquired factor V Inhibitor with rituximab and steroids. Haemophilia. 2016 May; 22(3):e231-2.

View in: PubMed
Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay. J Thromb Haemost. 2015 Jan; 13(1):47-53.

View in: PubMed
Muzaffar J, Katragadda L, Haider S, Javed A, Anaissie E, Usmani S. Rituximab and intravenous immunoglobulin (IVIG) for the management of acquired factor VIII inhibitor in multiple myeloma: case report and review of literature. Int J Hematol. 2012 Jan; 95(1):102-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals